PGNY Q4 2024 Earnings — Progyny, Inc. Revenue & Financial Results | Market Cap Arena

PGNYProgyny, Inc.

$1B

Q4 2024 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$298M+10.6% YoY

Gross Profit

$63M21.3% margin

Operating Income

$16M5.3% margin

Net Income

$11M3.5% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

+4.1%

Cash Flow

Operating Cash Flow

$52M

Free Cash Flow

$50M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$607M

Total Liabilities

$185M

Stockholders' Equity

$422M

Cash & Equivalents

$162M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$298M	$270M	+10.6%
Gross Profit	$63M	$57M	+11.5%
Operating Income	$16M	$14M	+14.4%
Net Income	$11M	$13M	-21.8%

Revenue Segments

Fertility benefit services revenue

$381M63%

Pharmacy benefit services revenue

$221M37%